Stock ELDN ELEDON PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Eledon Pharmaceuticals, Inc.

Equities

ELDN

US28617K1016

Real-time Estimate Cboe BZX
Other stock markets
 19:49:32 03/06/2024 BST 		5-day change 1st Jan Change
2.795 USD +1.64% Intraday chart for Eledon Pharmaceuticals, Inc. +8.53% +55.56%
05-13 Eledon Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
05-09 Eledon Pharmaceuticals, Inc. announced that it has received $49.99901 million in funding CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
ELEDON PHARMACEUTICALS, INC. Stock Eledon Pharmaceuticals, Inc.
 106M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 118B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 24.28B -
ARGENX SE Stock argenx SE
 21.96B -
GENMAB A/S Stock Genmab A/S
 18.16B
  1. Stock Market
  2. Equities
  3. ELDN Stock
  4. Charts Eledon Pharmaceuticals, Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW